Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 146
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT06958939 The Safety and Efficacy of S103 in the Treatment of Refractory Generali… |
Dose level 1 group | Myasthénie | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Ting Chang, MD | China · The Second Affiliated Hospital of Air Force M… | 2025-05-01 → 2028-04-30 | Ouvrir |
| NCT06700616 MG Cohort — A Study in Patients With Myasthenia Gravis in China |
MG Cohort — A Study in Patients W… | Myasthénie | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | AstraZeneca | China · Research Site, Beijing, China | Research Site… | 2024-09-26 → 2027-12-30 | Ouvrir |
| NCT06002945 EXPLORE-MG2 — Exploring Outcomes and Characteristics of Myasthenia Grav… |
EXPLORE-MG2 — Exploring Outcomes … | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Yale University | United States · Cedars Sinai Medical Center, Los Ange… | 2021-01-12 → 2025-05-31 | Ouvrir |
| NCT07570589 REAL MG PRO — Monitor the Evolution of Myasthenia Gravis Symptoms in Re… |
REAL MG PRO — Monitor the Evoluti… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · Ch de Boulogne sur Mer, Boulogne-sur-Mer, Fr… | 2026-06-15 → 2028-03 | Ouvrir |
| NCT07649187 Depressive Tendency and Counseling Outcomes in Thymoma-Associated MG |
Depressive Tendency and Counselin… | Myasthénie | Non applicable | COMPLETED | En attente / non publié | Ming-Hsing Chang | Taiwan · Shin Kong Wu Ho-Su Memorial Hospital, Taipei… | 2024-01-01 → 2025-12-31 | Ouvrir |
| NCT06866652 MyaRESP — Evaluating Dyspnea in Autoimmune Myasthenia Gravis "Why am I … |
MyaRESP — Evaluating Dyspnea in A… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Institut de Myologie, France | France · Institute of Myology, Paris, France | 2026-04-08 → 2028-06 | Ouvrir |
| NCT05556096 Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia G… |
ALXN1720 | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | United States, Argentina, Austria, Brazil, Canada, Ch… | 2022-11-21 → 2027-08-31 | Ouvrir |
| NCT06909253 MG-ARCADIA — Ravulizumab Treatment Outcomes in Patients With Generalize… |
Ravulizumab | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Alexion Pharmaceuticals, Inc. | Poland · Research Site, Bydgoszcz, Poland | Research … | 2025-05-15 → 2029-12-31 | Ouvrir |
| NCT03490539 PROMISE-MG — Disease-Modifying Treatments for Myasthenia Gravis |
Mycophenolate Mofetil | Myasthénie | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States, Canada · Beth Israel Deaconess Medical… | 2018-05-07 → 2021-01-31 | Ouvrir |
| NCT06414954 SYNAPSE-MG — Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Pa… |
NMD670 | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | NMD Pharma A/S | United States, Belgium, Denmark, France, Georgia, Ita… | 2024-05-16 → 2026-12 | Ouvrir |
| NCT07677852 MYAOUS — Sexual and Urinary Dysfunctions in Generalized Myasthenia |
MYAOUS — Sexual and Urinary Dysfu… | Myasthénie | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Centre Hospitalier Universitaire … | France · APHP and Myology institute, Paris, France | … | 2026-07-30 → 2030-07-30 | Ouvrir |
| NCT06743490 CAPTURE - MG — Capturing Key MG-symptoms Using Smartphone Recordings. |
CAPTURE - MG — Capturing Key MG-s… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2025-03-18 → 2026-09-30 | Ouvrir |
| NCT06659627 FIT to ACT-MG — Interventions Against Fatigue in Patients With Myasthen… |
FIT to ACT-MG — Interventions Aga… | Myasthénie | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Leiden University Medical Center | Netherlands · Leiden University Medical Center, Leide… | 2024-12-04 → 2027-01-23 | Ouvrir |
| NCT05070858 NIMBLE — A Study to Test How Safe Pozelimab and Cemdisiran Combination … |
Pozelimab + Cemdisiran | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Regeneron Pharmaceuticals | United States, Belgium, Brazil, Canada, China, Denmar… | 2021-12-14 → 2028-11-11 | Ouvrir |
| NCT07714798 Universal STAR-T Cell Injection in Generalized Myasthenia Gravis |
Universal STAR-T Cell | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Daishi Tian | China · Tongji Hospital Affiliated to Tongji Medical … | 2026-07-06 → 2028-07-06 | Ouvrir |
| NCT07717281 PANORAMA: Neuromuscular Organoids for Refractory AChR+ Myasthenia Gravis |
PANORAMA: Neuromuscular Organoids… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Fondazione IRCCS Ca' Granda, Ospe… | Italy · Fondazione IRCCS Ca' Granda Ospedale Maggiore… | 2026-06-04 → 2028-03-31 | Ouvrir |
| NCT06282159 A Phase 2 Study to Evaluate DNTH103 in Adults With Generalized Myasthen… |
Claseprubart | Myasthénie | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Dianthus Therapeutics | United States, Argentina, Canada, Czechia, Denmark, F… | 2024-02-23 → 2028-10 | Ouvrir |
| NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthen… |
Nipocalimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Australia, Belgium, Canada, China, Cze… | 2021-07-15 → 2029-03-29 | Ouvrir |
| NCT06558279 ADAPT oculus — A Study to Assess Efficacy and Safety of Efgartigimod PH… |
Efgartigimod PH20 SC | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Australia, Austria, Belgium, Canada, C… | 2024-09-18 → 2027-12 | Ouvrir |
| NCT07039916 Study to Assess the Efficacy and Safety of IMVT-1402 in Participants Wi… |
IMVT-1402 | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Immunovant Sciences GmbH | United States, Argentina, Czechia, Denmark, Georgia, … | 2025-05-27 → 2028-12 | Ouvrir |
| NCT07294170 ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Saf… |
Efgartigimod IV | Myasthénie | À vérifier | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06435312 ziMyG+ — An Open-label Extension Study to Evaluate Subcutaneous Zilucop… |
Zilucoplan | Myasthénie | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | UCB Biopharma SRL | Italy, Poland, South Korea, United Kingdom · Mg0015 2… | 2024-11-19 → 2027-11-19 | Ouvrir |
| NCT07075627 A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eato… |
A Study to Evaluate the Incidence… | Myasthénie | À vérifier | WITHDRAWN | En attente / non publié | Addario Lung Cancer Medical Insti… | United States · Dana-Farber Cancer Institute, Boston,… | 2025-09 → 2026-12 | Ouvrir |
| NCT06259071 MuSK 1000 — MuSK Myasthenia 1000 Study |
MuSK 1000 — MuSK Myasthenia 1000 … | Myasthénie | À vérifier | RECRUITING | En attente / non publié | George Washington University | United States · George Washington University, Washing… | 2023-08-23 → 2027-12-31 | Ouvrir |
| NCT06298552 ADAPT SERON — A Phase 3 Study to Evaluate the Efficacy and Safety of Ef… |
Efgartigimod IV | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Belgium, Canada, China, Cyprus, Czechi… | 2024-04-16 → 2028-06 | Ouvrir |